On pre-operative MRI, HER2+ cancers demonstrate higher rates of multicentric/multifocal disease13, skin-nipple-periareolar involvement18 and increased rate of rapid early contrast uptake19 compared to other molecular subtypes. This evidence concerns the gene ERBB2 and cancer.